Commentary on Effects of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy Alone on Survival in Glioblastoma in a Randomised Phase III Study: 5-Year Analysis of the EORTC-NCIC Trial (Lancet Oncol. 2009;10:459-466)

被引：79
作者：
Linz, Ute [1 ]
机构：
[1] Juelich Res Ctr, Inst Neurosci & Biophys, Julich, Germany
来源：
CANCER | 2010年 / 116卷 / 08期
关键词：
glioblastoma; chemotherapy; temozolomide; nimustine; Neuro-Oncology Working Group of the German Cancer Society; European Organization for Research and Treatment of Cancer; CHEMOTHERAPY;
D O I：
10.1002/cncr.24950
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Recently, un update of the important European Organization for Research and Treatment of Cancer study 26981 was published without correcting deficiencies that already were known and publicized in 2008. In the current commentary, the author specifies those issues to help prevent incorrect conclusions and discusses reasons why the journal that published the update dismissed a letter clarifying those shortcomings. Cancer 2010;116:1844-6. (C) 2070 American Cancer Society
引用
收藏
页码：1844 / 1846
页数：3
相关论文
共 5 条
  • [1] Chemotherapy for Glioblastoma IS Costly Better?
    Linz, Ute
    [J]. CANCER, 2008, 113 (10) : 2617 - 2622
  • [2] Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
    Stupp, R
    Mason, WP
    van den Bent, MJ
    Weller, M
    Fisher, B
    Taphoorn, MJB
    Belanger, K
    Brandes, AA
    Marosi, C
    Bogdahn, U
    Curschmann, J
    Janzer, RC
    Ludwin, SK
    Gorlia, T
    Allgeier, A
    Lacombe, D
    Cairncross, JG
    Eisenhauer, E
    Mirimanoff, RO
    Van Den Weyngaert, D
    Kaendler, S
    Krauseneck, P
    Vinolas, N
    Villa, S
    Wurm, RE
    Maillot, MHB
    Spagnolli, F
    Kantor, G
    Malhaire, JP
    Renard, L
    De Witte, O
    Scandolaro, L
    Vecht, CJ
    Maingon, P
    Lutterbach, J
    Kobierska, A
    Bolla, M
    Souchon, R
    Mitine, C
    Tzuk-Shina, T
    Kuten, A
    Haferkamp, G
    de Greve, J
    Priou, F
    Menten, J
    Rutten, I
    Clavere, P
    Malmstrom, A
    Jancar, B
    Newlands, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10) : 987 - 996
  • [3] Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
    Stupp, Roger
    Hegi, Monika E.
    Mason, Warren P.
    van den Bent, Martin J.
    Taphoorn, Martin J. B.
    Janzer, Robert C.
    Ludwin, Samuel K.
    Allgeier, Anouk
    Fisher, Barbara
    Belanger, Karl
    Hau, Peter
    Brandes, Alba A.
    Gijtenbeek, Johanna
    Marosi, Christine
    Vecht, Charles J.
    Mokhtari, Karima
    Wesseling, Pieter
    Villa, Salvador
    Eisenhauer, Elizabeth
    Gorlia, Thierry
    Weller, Michael
    Lacombe, Denis
    Cairncross, J. Gregory
    Mirimanoff, Rene-Olivier
    [J]. LANCET ONCOLOGY, 2009, 10 (05) : 459 - 466
  • [4] VERLEYE L, 2008, INT GYN CANC SOC 12
  • [5] Neuro-oncology working group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma
    Weller, M
    Müller, B
    Koch, R
    Bamberg, M
    Krauseneck, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) : 3276 - 3284
1